PotNetwork Holding, Inc. (POTN) Q3 Earnings Set To Make Another New Record?
(POTN) could now be on pace to generate more revenue than originally expected this year. With than $5 million in revenue recorded during the first half of 2017, that may have been just the tip of the iceberg. In the months of July and August (as of this week’s release), the company generated more than $3.2 million in revenue. With September still yet to be reported, POTN could be on pace to outperform their previous record breaking revenues from Q2!
Marijuana Stocks Update: (GTBP) Just Took Serious Measures…
“This amendment is beneficial to all shareholders in helping to preserve share value as GT Biopharma continues to progress towards its goal of moving onto the NASDAQ exchange,” said Executive Chairman Anthony Cataldo…
Social Media’s Relationship With the Cannabis Community?
To say that the marijuana market is rapidly changing for the better for mostly all involved could be a major understatement. But, until our nation comes to a solution on the federal prohibition marijuana businesses will face subjective decisions from major companies that are considered “legal”. Unfortunately, any type of marijuana company faces scrutiny and prejudice from those that do not understand the benefits that these companies bring to many, especially the ill.
MAPH Enterprises LLC., has been compensated a total $150,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We have been previously paid $21,000 (CASH) for coverage on Potnetwork Holdings, which has since expired. We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. An affiliate of MAPH Enterprises LLC, Midam Ventures has been compensated $800,000 by GT Biopharma, Inc. (GTBP) for a period beginning August 1st, 2017 and ending November 1st, 2017 to publicly disseminate information about GT Biopharma, Inc. (GTBP). We own zero shares of (GTBP). We may buy or sell additional shares of (POTN,GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.